PROTAC BRD4 Degrader 2 | Interleukin Related interleukin-related.com

Product Name :
PROTAC BRD4 Degrader 2

Search keywords :
PROTAC BRD4 Degrader-2

drugId :
null

Target Vo:
Bromodomain-containing protein 4

Target Vo Short Name :
BRD4

Moa_Name:
Bromodomain-containing protein 4 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
China Pharmaceutical University

Active Company_Name :
China Pharmaceutical University

Active Indication_Name:
Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:
Preclinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Spesolimab In Vivo
Cdk2 Rabbit mAb References
Phospho-ASK1 (Ser966) Antibody: Phospho-ASK1 (Ser966) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 155 kDa, targeting to Phospho-ASK1 (Ser966). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts